Results 91 to 100 of about 327 (169)

[Association of the structure of the glucocorticoid receptor and single nucleotide NR3C1 gene polymorphisms with metabolic disorders]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2023
Brovkina SS   +6 more
europepmc   +1 more source

Сравнение эффективности первой линии терапии разными поколениями ингибиторов EGFR-тирозинкиназы у пациентов с распространенным EGFR-ассоциированным немелкоклеточным раком легкого: сетевой метаанализ данных общей выживаемости

open access: yes
The lack of trials directly comparing 2nd and 3rd generation EGFR tyrosine kinase inhibitors (TKI) do not allows to determine the optimal treatment approach.
Моисеенко Ф.В.   +4 more
core  

[Adipocytokines: modern definition, classification and physiological role]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2021
Markova TN, Mishchenko NK, Petina DV.
europepmc   +1 more source

[Polycystic ovary syndrome: new and promising treatment methods]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Gasieva DM   +4 more
europepmc   +1 more source

[Effect of bone anabolic therapy on bone remodeling and bone density in geriatric patients with osteoporosis and falling syndrome]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2022
Khovasova NO   +5 more
europepmc   +1 more source

[The use of tocilizumab in severe glucocorticoid-resistant endocrine ophthalmopathy with optic neuropathy in clinical practice]. [PDF]

open access: yesProbl Endokrinol (Mosk)
Sviridenko NY   +9 more
europepmc   +1 more source

[Semaglutide - effectiveness in weight loss and side effects when used according to studies by SUSTAIN, PIONEER, STEP]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2023
Shabutdinova OR   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy